Combined, functional genomic-biochemical approach to intermediary metabolism: interaction of acivicin, a glutamine amidotransferase inhibitor, with Escherichia coli K-12

Journal of Bacteriology
D R SmulskiR A LaRossa

Abstract

Acivicin, a modified amino acid natural product, is a glutamine analog. Thus, it might interfere with metabolism by hindering glutamine transport, formation, or usage in processes such as transamidation and translation. This molecule prevented the growth of Escherichia coli in minimal medium unless the medium was supplemented with a purine or histidine, suggesting that the HisHF enzyme, a glutamine amidotransferase, was the target of acivicin action. This enzyme, purified from E. coli, was inhibited by low concentrations of acivicin. Acivicin inhibition was overcome by the presence of three distinct genetic regions when harbored on multicopy plasmids. Comprehensive transcript profiling using DNA microarrays indicated that histidine biosynthesis was the predominant process blocked by acivicin. The response to acivicin, however, was quite complex, suggesting that acivicin inhibition resonated through more than a single cellular process.

References

Nov 1, 1975·Proceedings of the National Academy of Sciences of the United States of America·J C StephensB N Ames
May 15, 1991·Proceedings of the National Academy of Sciences of the United States of America·B ThönyA Kornberg
Oct 5, 1990·Journal of Molecular Biology·S F AltschulD J Lipman
Aug 1, 1990·Molecular Microbiology·J Davies
Jan 1, 1985·Advances in Enzyme Regulation·N Prajda
Dec 22, 1986·Nucleic Acids Research·J G Petersen, S Holmberg
May 1, 1987·Molecular & General Genetics : MGG·T K Van Dyk, R A LaRossa
Oct 5, 1988·Journal of Molecular Biology·M S CarlomagnoC B Bruni
Sep 1, 1987·BioEssays : News and Reviews in Molecular, Cellular and Developmental Biology·R A LaRossa, T K Van Dyk
Jan 15, 1985·Biochemical Pharmacology·W L Elliott, G Weber
May 1, 1972·Canadian Journal of Microbiology·M L Murray, P E Hartman
Oct 1, 1970·Genetics·E P GoldschmidtA Greene
Oct 1, 1970·Genetics·L Garrick-Silversmith, P E Hartman
Jan 1, 1984·Advances in Enzyme Regulation·G WeberW L Elliott
Sep 12, 1995·Proceedings of the National Academy of Sciences of the United States of America·P K Chatterjee, N L Sternberg
Mar 14, 1995·Proceedings of the National Academy of Sciences of the United States of America·T K SmithA Meister
May 1, 1994·Applied and Environmental Microbiology·T K Van DykR A LaRossa
Oct 1, 1993·Applied and Environmental Microbiology·M S Johnson, B L Taylor
Apr 1, 1996·Molecular and Biochemical Parasitology·A S Hussein, R D Walter
Jan 1, 1997·Journal of Bacteriology·P ZhouC E Helmstetter
Sep 1, 1997·Nucleic Acids Research·S F AltschulD J Lipman
Sep 5, 1997·Science·F R BlattnerY Shao
Jul 29, 1998·Methods in Molecular Biology·T K Van Dyk, R A Rosson
Jul 29, 1998·Methods in Molecular Biology·D A Elsemore
Sep 11, 1999·Nucleic Acids Research·C S RichmondF R Blattner

❮ Previous
Next ❯

Citations

Oct 18, 2006·Applied Microbiology and Biotechnology·Armin Ehrenreich
May 7, 2003·Current Opinion in Microbiology·Virgil A Rhodius, Robert A LaRossa
Nov 10, 2011·The Journal of Biological Chemistry·Ján BurianCharles J Thompson
Mar 5, 2013·Applied and Environmental Microbiology·Mikiro Hayashi, Kazuhiko Tabata
Nov 28, 2007·Journal of Bacteriology·Tim DurfeeDing Jun Jin
Oct 19, 2004·Journal of Bacteriology·Tina K Van DykF Sima Sariaslani
Jan 14, 2004·Proceedings of the National Academy of Sciences of the United States of America·Partha MukhopadhyayGisela Storz
Feb 13, 2016·The Journal of Antimicrobial Chemotherapy·Marlen AdlerLinus Sandegren
Feb 13, 2003·Molecular Microbiology·Tyrrell Conway, Gary K Schoolnik
Oct 11, 2005·Drug Discovery Today·Michelle D Brazas, Robert E W Hancock
Jul 27, 2002·Annual Review of Microbiology·Virgil RhodiusRobert A LaRossa
Oct 31, 2012·Expert Review of Anti-infective Therapy·Ján BurianCharles J Thompson
Sep 5, 2007·Microbiology·Meranda D BradleyRobert Osuna
Aug 1, 2009·EcoSal Plus·Malcolm E Winkler, Smirla Ramos-Montañez

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.